Journal article

Tolerance to acetyl-salicylic acid in NSAID-exacerbated respiratory disease after biological therapies with benralizumab, dupilumab, mepolizumab or omalizumab

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

López, J., Garcia, E., Alvarez, A. M. C., Buendía, J.-A., & Sanchez, J. (2023). Tolerance to acetyl-salicylic acid in NSAID-exacerbated respiratory disease after biological therapies with benralizumab, dupilumab, mepolizumab or omalizumab. Journal of Allergy and Clinical Immunology, 151(S2).

MLA Style

López, J., et al. “Tolerance to Acetyl-Salicylic Acid in NSAID-Exacerbated Respiratory Disease after Biological Therapies with Benralizumab, Dupilumab, Mepolizumab or Omalizumab.” Journal of Allergy and Clinical Immunology, vol. 151, no. S2, Elsevier, 2023.

Chicago Style

López, J, E Garcia, AMC Alvarez, J-A Buendía, and J Sanchez. 2023. “Tolerance to Acetyl-Salicylic Acid in NSAID-Exacerbated Respiratory Disease after Biological Therapies with Benralizumab, Dupilumab, Mepolizumab or Omalizumab.” Journal of Allergy and Clinical Immunology 151 (S2).
Share
Print

Access Document

Publisher copy:: 10.1016/j.jaci.2022.12.196

Authors

+ López, J More by this author

Role:: Author

+ Garcia, E More by this author

Role:: Author

+ Alvarez, AMC More by this author

Role:: Author

+ Buendía, J-A More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Population Health
Role:: Author
ORCID:: 0000-0003-2404-6612

+ Sanchez, J More by this author

Role:: Author

Publisher:: Elsevier
Journal:: Journal of Allergy and Clinical Immunology More from this journal
Volume:: 151
Issue:: S2
Article number:: AB62
Publication date:: 2023-02-01
DOI:: 10.1016/j.jaci.2022.12.196
ISSN:: 0091-6749

Language:: English
Keywords:: biomedical and clinical sciences

immunology

good health and well being

FFR
Pubs id:: 1490948
Local pid:: pubs:1490948
Deposit date:: 2023-07-08

Terms of use

Copyright holder:: Elsevier Inc.
Copyright date:: 2022
Rights statement:: © 2022 Published by Elsevier Inc.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP